A staggering 62% of women suffer from urinary incontinence (UI). Flyte is a women-led medical device company on a mission to change this paradigm, using novel technology to transform the conservative standard of care for UI.
Our medical device, Flyte, is transforming the lives of women diagnosed with urinary incontinence by providing a clinically proven, convenient, and effective solution that empowers both women and healthcare professionals to address incontinence early - at point of diagnosis.
The Flyte System is an FDA-cleared, novel, in-home treatment for stress urinary incontinence demonstrated in two published clinical trials to deliver continence rates and durability comparable to surgery in a first line, accessible (in-home) treatment.
Flyte is prescribed by Family Medicine, OB/GYN, and Urology as an alternative to surgery, in-person treatment, and bulking agents.
Flyte is the first pelvic floor product to use the proven modality of mechanotherapy to treat urinary incontinence.